
Lumoral® innovation
According to EFP treatment recommendations, professional and home supragingival biofilm control is highly recommended for all periodontitis patients. However, the EFP does not recommend traditional photodynamic therapy (aPDT). The lack of suitable light sources has slowed its widespread adoption, and in dentistry it has mainly been used in clinics utilizing laser light. Studies show that treatment should be given regularly to achieve a lasting effect, but the method has been limited to expensive, one-off treatments.
Lumoral® offers a solution to this need. Using the latest LED technology, Lumoral® brings this scientifically proven method to home use for the first time. This opens up the possibility of utilising its full potential in a new way: safely, regularly and cost-effectively.

The principle of Lumoral® treatment
Lumoral® combines four technological effects into one effective treatment.

Could Lumoral solve your patients' problem?

Lumoral for Periodontitis
Periodontitis is a disease of the gingival attachment tissues that develops from gingivitis. A critical factor that leads to periodontitis is plaque, which forms on the tooth surface as residual plaque hardens due to minerals in saliva. Tartar buildup always causes gingivitis.
Lumoral is used to prevent tartar buildup, especially in areas of the mouth that are difficult to clean but easily accumulate tartar such as molars and dental prostheses. Lumoral treats periodontitis by eliminating plaque and by reducing gingival bleeding, and the number of deepened gingival pockets (Pakarinen et al. 2022).

Lumoral for Implant health
One dental implant is lost every four minutes around the world. Implant diseases include peri-implant mucositis and peri-implantitis. These are inflammatory conditions of the attachment tissues. Implants must be treated carefully, perhaps even more carefully than natural teeth. Implant threads are a very good retention site for biofilm bacteria, as they are difficult to clean even by professionals.
The need to prevent bacterial problems and tartar buildup is, therefore, highly importantwhen aiming for a long implant life. Lumoral helps eliminate biofilm before it hardens into tartar, making it easier to keep the artificial root clean.

Lumoral for Halitosis
Poor oral hygiene is the most common cause of halitosis, or bad breath. Mechanical cleaning does not reach all the odor-producing bacterial masses, so the mouth can smell bad even if good oral hygiene is maintained.
Using Lumoral eliminates foul-smelling bacteria from areas where the cleaning equipment could not reach. The tongue also often collects a lot of bacterial mass, which is difficult to remove because of the bacteria's attachment to the tongue's surface. Lumoral treatment eliminates the bacteria, and the tongue becomes cleaner compared to active mechanical tongue cleaning.

Lumoral for Gingivitis
95% of all oral diseases are caused by bacteria, and most of them could be prevented if gingivitis could be cured early. Lumoral is a light-activated solution for oral health. It is the state-of-the-art treatment for managing bacterial plaque, while supporting oral flora.
Lumoral effectively treats gingivitis by affecting plaque volume and gum bleeding (Pakarinen et al. 2022).

Lumoral for Caries
Lumoral treatment is based on a unique combination of double light, a reaction that produces reactive oxygen. An enzyme called catalase defends against reactive oxygen, and streptococcal bacteria lack this enzyme.
Streptococcus mutans is one of the most important caries-causing bacteria. The mutans bacterium forms a protective layer on the surface of the biofilm, so when we target mutans with Lumoral, we are also acting on the biofilm as a whole.

Lumoral for Orthodontics
Sometimes orthodontic treatment must be discontinued if teeth are at risk of decay. Lumoral removes biofilm from areas that cannot be reached effectively by mechanical cleaning alone.
Lumoral reduces the risk of caries, halitosis, and gum disease and it facilitates mechanical cleaning. Bacteria are more easily eliminated from the mouth once they are dead.
For the patient's benefit
If you could recommend something to your patient that would really help, why wouldn't you do it?
I have type II diabetes, which led to periodontal disease. With guidance from my dentist, I’ve always taken my oral care seriously using an electric toothbrush and interdental brushes. But once I added Lumoral to my routine every morning and evening, things really changed. My dentist and dental hygienist have been amazed by the improvement: inflammation is under control, my gum pockets have reduced, and I have no plaque. I truly recommend Lumoral.
– Charlotte B., Lumoral® user
My dentist recommended this device when my gums and mucous membranes had become so sensitive that even a simple tartar removal wasn’t possible. I felt frustrated and a bit helpless at that point. After just ten uses, everything changed — my dentist immediately noticed how much healthier my gums and oral tissues looked. That moment felt like a huge step forward for me. I’m truly grateful for this innovation and the comfort it has brought back into my life.
– Amelia W., Lumoral® user
I’d been eyeing this device for a long time, but honestly, I wasn’t sure it would really make a difference. Then my dentist recommended it and explained the background and development behind it, and that conversation gave me the confidence to go ahead and order. It wasn’t a cheap purchase, but it has absolutely been worth it. The results speak for themselves. My only wish is that I had gotten it sooner — I can see now how much healthier my mouth would already be.
– Sophie K., Lumoral® user
I began using the device about two years ago after my dentist recommended it to help with my dry mouth. Since then, it’s made a real difference — my gums feel healthier and more protected. The results have been so good that we’re now getting one for my husband too.
– Hannah L., Lumoral® user



Image: Lumoral Clinical Studies – Updated 04 April 2025
KHE2021 Metro / HOPE-CP - Periodontitis stage 1-3
• Timo Sorsa, Saila Pakarinen, Hanna-Mari Välimaa, Marja Noponen, Heikki Alapulli, Petri Auvinen
• 100+100 patients
• Sponsored, prospective, randomized
• Started: March 2022
• ClinicalTrials.gov ID: NCT05278416
• Preliminary results: https://doi.org/10.3390/dj10110206
LumoNorth2022 - Periodontitis stage 1-3
• Timo Sorsa, Paula Tegelberg, Meeri Ojala, Merja Ylipalosaari, Jori Lindroth, Petri Auvinen
• 45+45 patients
• Sponsored, prospective randomized, multicenter
• Started: Jan 2023
• ClinicalTrials.gov ID: NCT05425784
THSS1 - Smoking periodontitis patients
• Dimitra Sakellari, Timo Sorsa, Chrysoula Vakaki, Aikaterini- Elisavet Doufexi, Ismo Räisänen, Tommi Pätilä
• 30+30 patients
• Investigator-initiated, prospective, randomized, blinded
• Started Jan 2023
• ClinicalTrials.gov ID: NCT05962801
LumoKaunas2023, Periodontitis stage 3-4
• Ingrida Marija Pacauskienė, Nomeda Basevičienė, Vita Mačiulskienė, Raimonda Guntulytė, Alma Pranckevičienė, Renata Šadzevičienė, Petri Auvinen, Ismo Räisänen, Timo Sorsa
• Sponsored, prospective, randomized
• Started June 2023
• ClinicalTrials.gov ID: NCT05698823
LumoKoti, oral hygiene with elderly people living at home or at care home
• Timo Sorsa, Harry Niskanen, Pekka Kallio, Tommi Pätilä, Katja Gustafsson, Karim Abdalla
• Investigator-initiated, prospective, randomized
• Estimated start: Q2-Q3/2024
• ClinicalTrials.gov ID: TBA
IS-2022 Enhanced oral hygiene effect on the implant success rate
• Hellevi Ruokonen, Karita Nylund, Timo Sorsa, Tommi Pätilä, Patricia Stoor, Nina-Li Avellán, Kirsten Besuch, Viivi Mattila, Petri Auvinen
• Investigator-initiated, prospective, randomized
• Started: Sep 2022
IS-TRE Prevention of peri-implant diseases
• Hanna Lähteenmäki, Timo Sorsa, Tommi Pätilä, Ismo Räisänen
• Investigator-initiated, prospective, randomized
• Study ended: July 2023
• Study report by Q2/2024
• ClinicalTrials.gov ID: NCT05871229
Severe peri-implantitis
• Nilminie Rathnayake, Timo Sorsa, Taina Tervahartiala, Akke Kumlien, Tommi Pätilä
• Investigator-initiated, prospective, randomized
• Estimated start: Q1/2024
• ClinicalTrials.gov ID: NCT06017817
OLP-01TRE Treatment of oral lichen planus
• Anna Maria Heikkinen, Kati Ylä-Tuuhonen, Timo Sorsa, Jaana Hagström, Ulla Kotiranta, Taina Tervahartiala, Esko Kankuri, Outi Majala
• Sponsored, prospective, randomized
• Started: Jan 2023
• ClinicalTrials.gov ID: NCT05401201
CLEAN-BRACKET Fixed orthodontic treatment in adolescents
• Ann-Marie Roos Jansåker, Katja Elses, My Blomqvist, Petri Auvinen
• Sponsored, prospective, randomized
• Started: Nov 2023
• ClinicalTrials.gov ID: NCT05825742
LumOsteo Prevention of osteolysis after dental implant surgery
• Pekka Kallio, Timo Strandén
• Investigator-initiated, prospective, randomized
• Estimated start: Q1/2024
• ClinicalTrials.gov ID: NCT06041828
RSAA2021 Enhanced oral hygiene on elderly care home residents
• Riitta Saarela, Tommi Pätilä, Timo Sorsa, Jaana Helenius-Hietala, Anna Maria Heikkinen, Saila Pakarinen, Sakari Nikinmaa, Taina Tervahartiala, Sanna Korte, Wilma Romppanen, Tuuli Seitsamo
• Investigator-initiated, prospective, randomized
• Started: September 2022
• ClinicalTrials.gov ID: NCT05853679
Cleft palate operations - Enhanced oral hygiene
• Elisa Ronkainen, Juho Suojanen, Junnu Leikola, Arja Heliövaara
• Investigator-initiated, prospective
• Started: 2020
LumoPrevent / Targeting of Preventive Treatment for Adolescents at Risk of Oral Diseases
• Anna Maria Heikkinen, Milla Sarja, Teija Raivisto, Ismo Räisänen, Tommi Pätilä, Timo Sorsa, Saila Pakarinen
• Investigator-initiated, prospective, randomized
• Started: April 2024
• ClinicalTrials.gov ID: NCT06286501
APDT-T2D, management and prevention of periodontitis symptoms in diabetic patients
• Anna Maria Heikkinen, Patrick Saikkonen, Miia Ehrnrooth, Timo Sorsa, Andreas Pfuetzner, Marko Helenius, Pirkko Pussinen, Atte Vadén, Tommi Pätilä, Timo Kauppila
• Investigator-initiated, prospective, randomized
• Estimated start: Q3/2024
• ClinicalTrials.gov ID: TBA


